ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY

Bristol-Myers Squibb Company

Application Filed: 2011-04-14

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	85294803
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Marilyn F. Kelly
Law Office Assigned	L20
Employee Name	CHOSID, ROBIN S

Timeline

2011-04-14	Application Filed
2011-09-20	Published for Opposition
2012-05-10	Location: INTENT TO USE SECTION
2014-12-22	Abandon
2014-12-22	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Bristol-Myers Squibb Company
Address	345 Park Avenue New York DE 10154
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000

Good, Services, and Codes

International Codes:	42
U.S. Codes:	100,101

Type Code	Type
D10000	"APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY"

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2011-04-18	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-04-18	2 NWOS I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2011-04-19	3 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2011-04-19	4 ARAA I:Incoming Correspondence
TEAS VOLUNTARY AMENDMENT RECEIVED	2011-04-25	5 PARI I:Incoming Correspondence
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED	2011-04-25	6 TAEA I:Incoming Correspondence
ASSIGNED TO EXAMINER	2011-06-29	7 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED	2011-07-18	8 CPEA R:Renewal
EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED	2011-07-18	9 CEAP F:First Action
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2011-07-25	10 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2011-07-25	11 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2011-07-25	12 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2011-08-03	13 CNSA P:
ASSIGNED TO LIE	2011-08-16	14 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2011-08-17	15 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2011-08-31	16 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2011-09-20	17 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT	2011-11-15	18 NOAM O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2012-04-17	19 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2012-05-10	20 AITU A:Allowance for Publication
EXTENSION 1 FILED	2012-04-17	21 EXT1 S:
EXTENSION 1 GRANTED	2012-05-10	22 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED	2012-05-11	23 EXRA O:Outgoing Correspondence
TEAS EXTENSION RECEIVED	2012-11-08	24 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2012-11-08	25 EXT2 S:
EXTENSION 2 GRANTED	2012-11-13	26 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED	2012-11-14	27 EXRA O:Outgoing Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2013-03-12	28 TCCA I:Incoming Correspondence
TEAS EXTENSION RECEIVED	2013-05-03	29 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2013-05-03	30 EXT3 S:
EXTENSION 3 GRANTED	2013-05-06	31 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-05-07	32 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2013-11-13	33 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2013-11-13	34 EXT4 S:
EXTENSION 4 GRANTED	2013-11-18	35 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-11-19	36 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2014-05-08	37 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2014-05-08	38 EXT5 S:
EXTENSION 5 GRANTED	2014-05-12	39 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2014-05-13	40 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2014-12-22	41 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2014-12-22	42 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY 85294803 not registered Dead/Abandoned	Bristol-Myers Squibb Company 2011-04-14
ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY 77085410 not registered Dead/Abandoned	Bristol-Myers Squibb Company 2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.